GE HealthCare Secures $500M Credit Line, Replaces Expiring Facility

GE HealthCare Technologies Inc. (NASDAQ: GEHC) has secured a new $500 million revolving credit facility with JPMorgan Chase Bank, according to an 8-K filing with the SEC on February 27, 2026. The 364-day senior unsecured credit line replaces an identical facility that was terminated upon signing of the new agreement.

The Deal

The medical technology company entered into the 364-Day Revolving Credit Agreement on February 26, 2026, with JPMorgan Chase Bank serving as administrative agent alongside a syndicate of lenders. The new facility maintains the same $500 million capacity as its predecessor and will mature on February 25, 2027.

The credit line offers flexible borrowing options in multiple currencies, including U.S. dollars, euros, and British pounds sterling. Interest rates are variable and tied to benchmark rates—SOFR for dollar borrowings, EURIBOR for euros, and SONIA for sterling—plus an applicable margin determined by GE HealthCare's senior unsecured long-term debt ratings.

This new agreement replaces the previous 364-day facility dated March 27, 2025, which was scheduled to mature next month. The company terminated the existing facility without penalty concurrent with establishing the new credit line, ensuring continuous access to liquidity.

Strategic Rationale

The revolving credit facility serves as a financial safety net for GE HealthCare, providing immediate access to capital for general corporate purposes, working capital needs, or potential acquisition opportunities. As a relatively young independent company—having spun off from General Electric in January 2023—maintaining robust liquidity is crucial for operational flexibility.

The $500 million capacity represents approximately 2.7% of GE HealthCare's $18.3 billion in annual revenue reported for 2023, providing meaningful but manageable leverage capacity. The multi-currency borrowing option aligns with the company's global operations, as GE HealthCare generates significant revenue from international markets, particularly in Europe and Asia.

The timing of this refinancing, completed a month before the previous facility's expiration, demonstrates proactive treasury management. By securing the new credit line early, GE HealthCare avoided any potential market disruptions or unfavorable terms that could arise from last-minute negotiations.

The facility's structure as a revolving credit line rather than a term loan provides maximum flexibility—the company can draw funds as needed and repay without penalty, paying interest only on amounts actually borrowed. This structure is particularly valuable for managing seasonal cash flow variations or funding unexpected opportunities.

What to Watch

Investors should monitor several aspects of this credit facility going forward. The covenant structure includes important guardrails that provide insight into the company's financial health expectations. The agreement limits GE HealthCare's leverage ratio and restricts certain fundamental business changes, while also limiting subsidiary-level indebtedness.

The pricing mechanism tied to debt ratings creates an incentive for GE HealthCare to maintain or improve its credit profile. Any ratings changes by major agencies could impact borrowing costs under this facility. Currently rated Baa1 by Moody's and BBB+ by S&P, the company sits comfortably in investment-grade territory.

The one-year maturity suggests GE HealthCare views this as bridge financing rather than permanent capital structure. The company may seek to establish a longer-term facility or access bond markets if capital needs become more defined. Alternatively, strong cash generation could eliminate the need for renewal next year.

Regulatory considerations appear minimal for this straightforward refinancing transaction. The facility contains standard default provisions covering payment failures, covenant violations, and material adverse changes—typical protections for lenders that shouldn't constrain normal business operations.

The unchanged $500 million size from the previous facility suggests stable capital needs and confidence in current liquidity levels. GE HealthCare reported $2.7 billion in cash and equivalents at year-end 2023, indicating this credit line serves more as insurance than primary funding source.

For shareholders, this refinancing represents prudent financial management rather than a transformative event. The facility ensures GE HealthCare maintains financial flexibility without diluting equity or taking on permanent debt. As the company continues establishing its identity separate from General Electric, maintaining strong liquidity and banking relationships remains essential for long-term success.